NM_005379.4:c.3091A>G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_005379.4(MYO1A):c.3091A>G(p.Lys1031Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000109 in 1,613,974 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005379.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO1A | NM_005379.4 | c.3091A>G | p.Lys1031Glu | missense_variant | Exon 28 of 28 | ENST00000300119.8 | NP_005370.1 | |
MYO1A | NM_001256041.2 | c.3091A>G | p.Lys1031Glu | missense_variant | Exon 29 of 29 | NP_001242970.1 | ||
MYO1A | XM_047428876.1 | c.3091A>G | p.Lys1031Glu | missense_variant | Exon 29 of 29 | XP_047284832.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000120 AC: 30AN: 250000Hom.: 1 AF XY: 0.000118 AC XY: 16AN XY: 135272
GnomAD4 exome AF: 0.000113 AC: 165AN: 1461882Hom.: 2 Cov.: 31 AF XY: 0.0000963 AC XY: 70AN XY: 727242
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Lys1031Glu vari ant in MYO1A has been previously reported in one individual with hearing loss at tributed to two pathogenic variants in GJB2 (Shearer 2013). It has also been ide ntified in 0.02% (2/8600) of European American chromosomes by the NHLBI Exome Se quencing Project (http://evs.gs.washington.edu; dbSNP rs371613423). Computationa l analyses (amino acid biochemical properties, conservation, AlignGVGD, PolyPhen 2, SIFT) suggest this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical sign ificance of this variant cannot be determined with certainty at this time; howev er, based upon the identification of this variant in an individual with an alter nate cause of hearing loss (reported in Shearer 2013), we would lean towards a m ore likely benign role. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at